Julia Grüner

Julia Grüner

Auto-generated profile, based on publicly available information

Julia Grüner

Department of Neurology, University Hospital Würzburg, Würzburg, Germany

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2024 in Brain Communications
Verified
Journal Article
Open access
PDF file
TKThomas Klein
Thomas Klein
JGJulia Grüner
Julia Grüner
MBMaximilian Breyer
Maximilian Breyer
JSJan Schlegel
Jan Schlegel
NSNicole Michelle Schottmann
Nicole Michelle Schottmann
NÜNurcan Üçeyler
Nurcan Üçeyler
Acral burning pain triggered by fever, thermal hyposensitivity and skin denervation are hallmarks of small fibre neuropathy in Fabry disease, a life-threatening X-linked lysosomal storage disorder. Variants in the gene encoding alpha-galactosidase A may lead to impaired enzyme activity with cellular accumulation of globotriaosylceramide. To study the underlying pathomechanism of Fabry-associated small fibre neuropathy, we generated a neuronal in vitro disease model using patient-derived induced pluripotent stem cells from three Fabry patients and one healthy control. We further generated an isogenic control line via gene editing. We subjected induced pluripotent stem cells to targeted peripheral neuronal differentiation and observed intra-lysosomal globotriaosylceramide accumulations in somas and neurites of Fabry sensory neurons using super-resolution microscopy. At functional level, patch-clamp analysis revealed a hyperpolarizing shift of voltage-gated sodium channel steady-state inactivation kinetics in isogenic control neurons compared with healthy control neurons (P < 0.001). Moreover, we demonstrate a drastic increase in Fabry sensory neuron calcium levels at 39°C mimicking clinical fever (P < 0.001). This pathophysiological phenotype was accompanied by thinning of neurite calibres in sensory neurons differentiated from induced pluripotent stem cells derived from Fabry patients compared with healthy control cells (P < 0.001). Linear–nonlinear cascade models fit to spiking responses revealed that Fabry cell lines exhibit altered single neuron encoding properties relative to control. We further observed mitochondrial aggregation at sphingolipid accumulations within Fabry sensory neurites utilizing a click chemistry approach together with mitochondrial dysmorphism compared with healthy control cells. We pioneer pilot insights into the cellular mechanisms contributing to pain, thermal hyposensitivity and denervation in Fabry small fibre neuropathy and pave the way for further mechanistic in vitro studies in Fabry disease and the development of novel treatment approaches.

9 April 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LHLukas Hofmann
Lukas Hofmann
JGJulia Grüner
Julia Grüner
KKKatharina Klug
Katharina Klug
MBMaximilian Breyer
Maximilian Breyer
TKThomas KLEIN
Thomas KLEIN
NÜNurcan Üçeyler
Nurcan Üçeyler
Fabry disease (FD) is a lysosomal storage disorder of X-linked inheritance. Mutations in the α-galactosidase A gene lead to cellular globotriaosylceramide (Gb3) depositions and triggerable acral burning pain in both sexes as an early FD symptom of unknown pathophysiology. We aimed at elucidating the link between skin cells and nociceptor sensitization contributing to FD pain in a sex-associated manner. We used cultured keratinocytes and fibroblasts of 27 adult FD patients and 20 healthy controls. Epidermal keratinocytes and dermal fibroblasts were cultured and immunoreacted to evaluate Gb3 load. Gene expression analysis of pain-related ion channels and pro-inflammatory cytokines was performed in dermal fibroblasts. We further investigated electrophysiological properties of induced pluripotent stem cell (iPSC) derived sensory-like neurons of a man with FD and a healthy man and incubated the cells with interleukin 8 (IL-8) or fibroblast supernatant as an in vitro model system. Keratinocytes displayed no intracellular, but membrane-bound Gb3 deposits. In contrast, fibroblasts showed intracellular Gb3 and revealed higher gene expression of potassium intermediate/small conductance calcium-activated potassium channel 3.1 (KCa 3.1, KCNN4) in both, men and women with FD compared to controls. Additionally, cytokine expression analysis showed increased IL-8 RNA levels only in female FD fibroblasts. Patch-clamp studies revealed reduced rheobase currents for both iPSC neuron cell lines incubated with IL-8 or fibroblast supernatant of women with FD. We conclude that Gb3 deposition in female FD patient skin fibroblasts may lead to increased KCa3.1 activity and IL-8 secretion. This may result in cutaneous nociceptor sensitization as a potential mechanism contributing to a sex-associated FD pain phenotype.

1 January 2026 in Neurology Neuroimmunology & Neuroinflammation
Verified
Journal Article
Open access
JGJulia Grüner
Julia Grüner
ITIvan Talucci
Ivan Talucci
CKCarolin Kurth
Carolin Kurth
MBMarkus Bayer
Markus Bayer
LALuise Appeltshauser
Luise Appeltshauser
KDKathrin Doppler
Kathrin Doppler
Autoimmune nodopathy with anti-contactin1 (CNTN1) autoantibodies is a rare sensory-motor neuropathy characterized by subacute-onset sensory ataxia and variable disease courses. Comorbidities such as glomerulonephritis and diabetes mellitus are observed in some patients. The diversity in clinical presentation may reflect differences in the targeted CNTN1 epitopes. To investigate the relationship between clinical features and the underlying epitopes, we analyzed serum samples from 16 anti-CNTN1-positive patients. Binding epitopes were assessed using cell-based assays with recombinant CNTN1 variants and peptide microarrays. Epitope mapping in 16 patients revealed that 13 harbored antibodies targeting CNTN1 immunoglobulin (Ig) domains while 3 recognized fibronectin (Fn) domains. Glomerulonephritis was exclusively observed in patients with autoantibodies binding to the Ig domain, whereas diabetes mellitus and a chronic course of disease were more prevalent in patients with binding to the fibronectin domain. Our findings highlight the heterogeneity of anti-contactin1 nodopathies, suggesting that distinct epitope-binding patterns may underlie different clinical manifestations and may be associated with different pathogenic mechanisms and comorbidities.

28 September 2026 in Communications Biology
Verified
Journal Article
Open access
PDF file
PGPatricia García-Fernández
Patricia García-Fernández
TBThorsten Bischler
Thorsten Bischler
ASAnnemarie Sodmann
Annemarie Sodmann
JGJulia Grüner
Julia Grüner
MKMaximilian Koch
Maximilian Koch
CSClaudia Sommer
Claudia Sommer
Polyneuropathies (PNP) are diseases of the peripheral nervous system (PNS) whose pathophysiology remains poorly understood. Schwann cells (SC) are the principle glial cells in the PNS, and their dysfunction can lead to demyelination and secondary axonal degeneration, causing or exacerbating PNP. The study of SC can thus shed light on the molecular and cellular mechanisms involved in PNP. Protocols have been developed to isolate and culture human and animal SC from large amounts of starting material. The isolation of human SC from patients, where only small biosamples are available, remains a challenge. In this study, we present a protocol to culture human SC from ~4-mm diagnostic sural nerve biopsies and a comprehensive transcriptome analysis to characterize their phenotype. Our protocol allows the reproducible establishment of cultures containing proliferative human Schwann cells that can be stored, expanded, and used as tools for diagnostic applications.

10 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
NSNicole Michelle Schottmann
Nicole Michelle Schottmann
JGJulia Grüner
Julia Grüner
FBFrederik Bär
Frederik Bär
FKFranziska Karl-Schöller
Franziska Karl-Schöller
SOSabrina Oerter
Sabrina Oerter
NÜNurcan Üçeyler
Nurcan Üçeyler
Introduction Reprogramming of human induced pluripotent stem cells (iPSC) and their differentiation into specific cell types, such as induced sensory-like neurons (iSN), are critical for disease modeling and drug testing. However, the variability of cell populations challenges reliability and reproducibility. While various protocols for iSN differentiation exist, development of non-iSN cells in these cultures remains an issue. Therefore, standardization of protocols is essential. This study aimed to improve iSN culture conditions by reducing the number of non-iSN cells while preserving survival and quality of iSN. Methods iSN were differentiated from a healthy control iPSC line using an established protocol. Interventions for protocol optimization included floxuridine (FdU) or 1-β-D-arabinofuranosyl-cytosin-hydrochlorid (AraC) treatment, Magnetic-Activated Cell Sorting (MACS), early cell passaging, and replating. Cell viability and iSN-to-total-cell-count ratio were assessed using a luminescent assay and immunocytochemistry, respectively. Results Passaging of cells during differentiation did not increase the iSN-to-total-cell-count ratio, and MACS of immature iSN led to neuronal blebbing and reduced the iSN-to-total-cell-count ratio. Treatment with high concentrations and prolonged incubation of FdU or AraC resulted in excessive cell death. However, treatment with 10 μM FdU for 24 h post-differentiation showed the most selective targeting of non-iSN cells, leading to an increase in the iSN-to-total-cell count ratio without compromising the viability or functionality of the iSN population. Replating of iSN shortly after seeding also helped to reduce non-iSN cells. Conclusion In direct comparison to other methods, treatment with 10 μM FdU for 24 h after differentiation represents a promising approach to improve iSN culture purity, offering a potential benefit for downstream applications in disease modeling and drug discovery. However, further investigations involving multiple iPSC lines and optimization of protocol parameters are warranted to fully exploit the potential of this method and enhance its reproducibility and applicability. Overall, this study provides valuable insights into optimizing culture conditions for iSN differentiation and highlights the importance of standardized protocols in iPSC-based research.

25 December 2025 in Stem Cell Research
Verified
Journal Article
Open access
JGJulia Grüner
Julia Grüner
EKEva Klopocki
Eva Klopocki
NÜNurcan Üçeyler
Nurcan Üçeyler
Bortezomib-induced peripheral neuropathy (BIPN) is a frequent, dose-limiting side effect in multiple myeloma (MM) patients treated with the proteasome inhibitor bortezomib (BTZ). To study the pathophysiology of pain in BIPN, we generated three induced pluripotent stem cell (iPSC) clones from human dermal fibroblasts (hdF) of a MM patient who developed painful BIPN and carried two homozygous risk variants (rs2839629 and rs915854). All clones exhibited typical iPSC morphology, expressed pluripotency markers, possessed normal karyotypes, and differentiated into all three germ layers. This patient-specific iPSC line provides an in vitro model to investigate genetic susceptibility and molecular mechanisms underlying pain in BIPN.